Martin Kramer

1.1k total citations
22 papers, 699 citations indexed

About

Martin Kramer is a scholar working on Molecular Biology, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Martin Kramer has authored 22 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Epidemiology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Martin Kramer's work include Biochemical and Molecular Research (3 papers), Chronic Disease Management Strategies (2 papers) and Mitochondrial Function and Pathology (2 papers). Martin Kramer is often cited by papers focused on Biochemical and Molecular Research (3 papers), Chronic Disease Management Strategies (2 papers) and Mitochondrial Function and Pathology (2 papers). Martin Kramer collaborates with scholars based in Germany, United States and United Kingdom. Martin Kramer's co-authors include Sutheera Ratanasirintrawoot, Peter B. Rahl, Christopher J. Burke, Charles Y. Lin, Donna Neuberg, Hannah K. Long, Leonard I. Zon, Erin M. Langdon, Richard M. White and Charles K. Kaufman and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Martin Kramer

22 papers receiving 685 citations

Peers

Martin Kramer
Robert M. DeKroon United States
Baohe Tian United States
Julian R. Smith United States
Yoonsang Cho United States
Saule Naureckiene United States
Martin Kramer
Citations per year, relative to Martin Kramer Martin Kramer (= 1×) peers Marco Piccinini

Countries citing papers authored by Martin Kramer

Since Specialization
Citations

This map shows the geographic impact of Martin Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Kramer more than expected).

Fields of papers citing papers by Martin Kramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Kramer. The network helps show where Martin Kramer may publish in the future.

Co-authorship network of co-authors of Martin Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Kramer. A scholar is included among the top collaborators of Martin Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Kramer. Martin Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Boddupalli, Chandra Sekhar, Shiny Nair, Glenn S. Belinsky, et al.. (2022). Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapy. eLife. 11. 33 indexed citations
4.
Wang, Hongge, Matt Davison, Martin Kramer, et al.. (2022). Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy. Cells. 11(5). 913–913. 11 indexed citations
5.
Wang, Hongge, Matt Davison, Martin Kramer, et al.. (2019). Transmembrane protease serine 5: a novel Schwann cell plasma marker for CMT1A. Annals of Clinical and Translational Neurology. 7(1). 69–82. 35 indexed citations
6.
Saadatmand, Ali R., Christian Schnabel, Ivana Viktorinová, et al.. (2018). Ectopic expression of S28A-mutated Histone H3 modulates longevity, stress resistance and cardiac function in Drosophila. Scientific Reports. 8(1). 2940–2940. 15 indexed citations
7.
Cosner, Casey C., Martin Kramer, Michael L. Booker, et al.. (2017). Identification ofTrypanosoma bruceiAdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay. ACS Infectious Diseases. 3(7). 512–526. 13 indexed citations
8.
Crowther, Gregory J., Michael L. Booker, Min He, et al.. (2014). Cofactor-Independent Phosphoglycerate Mutase from Nematodes Has Limited Druggability, as Revealed by Two High-Throughput Screens. PLoS neglected tropical diseases. 8(1). e2628–e2628. 20 indexed citations
9.
White, Richard M., Jennifer N. Cech, Sutheera Ratanasirintrawoot, et al.. (2011). DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature. 471(7339). 518–522. 352 indexed citations
10.
Skerlj, Renato T., Cecilia M. Bastos, Michael L. Booker, et al.. (2011). Optimization of Potent Inhibitors of P. falciparum Dihydroorotate Dehydrogenase for the Treatment of Malaria. ACS Medicinal Chemistry Letters. 2(9). 708–713. 34 indexed citations
11.
White, Richard M., Jennifer N. Cech, Sutheera Ratanasirintrawoot, et al.. (2011). DHODH modulates transcriptional elongation in the neural crest and melanoma. Digital Access to Scholarship at Harvard (DASH) (Harvard University). 4 indexed citations
12.
Kramer, Martin, Jon Dang, Fabian Baertling, et al.. (2010). TTC staining of damaged brain areas after MCA occlusion in the rat does not constrict quantitative gene and protein analyses. Journal of Neuroscience Methods. 187(1). 84–89. 85 indexed citations
13.
Patel, Vishal, Michael L. Booker, Martin Kramer, et al.. (2008). Identification and Characterization of Small Molecule Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase. Journal of Biological Chemistry. 283(50). 35078–35085. 59 indexed citations
14.
Kramer, Martin, et al.. (1988). [Changes in liver enzyme values in the course of 36-hour alcohol intake].. PubMed. 25(2). 116–26. 1 indexed citations
15.
Kramer, Martin. (1958). Aktivierung proteolytischer Fermente bei Entz�ndungsreaktionen. Naunyn-Schmiedeberg s Archives of Pharmacology. 234(5). 432–8. 3 indexed citations
16.
Kramer, Martin. (1958). Zur antiphlogistischen Wirkung des Histaminliberators Compound 48/80, einiger Antihistaminica und einiger Antirheumatica. Naunyn-Schmiedeberg s Archives of Pharmacology. 233(2). 125–33. 1 indexed citations
17.
Kramer, Martin. (1956). Untersuchungen �ber die Pathogenese anaphylactoider �deme der Ratte. Naunyn-Schmiedeberg s Archives of Pharmacology. 228(1-2). 233–5. 2 indexed citations
18.
Kramer, Martin. (1956). Pharmakologische Differenzierung des Eiklar- und Dextran�dems der Ratte. Naunyn-Schmiedeberg s Archives of Pharmacology. 228(3). 302–6. 5 indexed citations
19.
Kramer, Martin. (1956). Die Bedeutung der Histaminfreisetzung durch Compound 48/80, Dextran und Eiereiwei� f�r die �dementstehung bei der Ratte. Naunyn-Schmiedeberg s Archives of Pharmacology. 228(4). 340–6. 4 indexed citations
20.
Kramer, Martin. (1955). Biochemische und pharmakologische Differenzierung der Wirkung �demerzeugender Substanzen. Naunyn-Schmiedeberg s Archives of Pharmacology. 225(1-2). 82–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026